Aled Williams has more than twenty-five years of leadership experience across pharma and biotech sectors. Mr Williams’ experience includes being Chief Executive Officer of Enthera Pharmaceuticals, Chief Business Officer at Polyneuron Pharmaceuticals and Chief Commercial Officer at both VectivBio and Therachon. Mr Williams’ prior experience includes more than seven years at Shire, where he was Vice President and Global Strategy Head and led three of the rare disease therapeutic areas, globally. Prior to Shire, he held leadership positions of increasing responsibility at Bristol-Myers Squibb, Novartis and Roche. Mr Williams originally trained in microbiology and started his career working in Public Health.